💊 A new international clinical trial found that oral semaglutide reduces the risk of major cardiovascular events by 14% in people with type 2 diabetes and heart or kidney disease. ️ The ...

Bonaca, MD, Director of Vascular Research, University of Colorado School of Medicine, and lead investigator of the STRIDE trial, said: “Semaglutide 1mg is the first medication in over 2 decades ...

The FBI says counterfeit versions of the drugs can cause health issues. The FBI is warning the public about counterfeit compounded weight loss drugs on the market that claim to contain semaglutide ...

The review found that people who took 2.4 milligrams (mg) of semaglutide lost more weight than those who took 1 mg of semaglutide. Semaglutide is the active ingredient in both Wegovy and Ozempic.

One study found that 68.9% of individuals taking a 15mg dosage of tirzepatide experienced adverse effects, while 64.2% of ...

The STRIDE trial showed that symptomatic PAD patients with type 2 diabetes treated with semaglutide 1mg for a year experienced substantial functional benefits related to their PAD compared to the ...

Patients who received semaglutide before MBS from 2017 to 2024 were matched 1:1 with patients who did not receive semaglutide before MBS using nearest-neighbor propensity score matching.

Results showed 51% of people treated with 0.5mg semaglutide compared with 36% of those treated with 0.75mg dulaglutide reached the treatment goal, and 68% of people on the 1mg semaglutide dose ...

Please provide your email address to receive an email when new articles are posted on . Semaglutide and tirzepatide were the least cost-effective of four obesity drugs examined in a ...